Pages that link to "Q46845154"

The following pages link to Immunomodulatory effects of Toll-like receptor-7 activation on chronic lymphocytic leukemia cells (Q46845154):

Displaying 37 items.

• Functional analysis of a dominant negative mutation of interferon regulatory factor 5 (Q33442833) (← links)
• Toll-like receptors on B-CLL cells: expression and functional consequences of their stimulation (Q33494116) (← links)
• Exploiting biological diversity and genomic aberrations in chronic lymphocytic leukemia (Q34056568) (← links)
• In acute myeloid leukemia, B7-H1 (PD-L1) protection of blasts from cytotoxic T cells is induced by TLR ligands and interferon-gamma and can be reversed using MEK inhibitors. (Q34154994) (← links)
• The pharmacokinetics of Toll-like receptor agonists and the impact on the immune system. (Q35018021) (← links)
• Inhibition of type 4 cyclic nucleotide phosphodiesterase blocks intracellular TLR signaling in chronic lymphocytic leukemia and normal hematopoietic cells. (Q35096709) (← links)
• Aberrant O-GlcNAcylation characterizes chronic lymphocytic leukemia (Q35183015) (← links)
• Toll-like receptor signaling pathway in chronic lymphocytic leukemia: distinct gene expression profiles of potential pathogenic significance in specific subsets of patients (Q35528659) (← links)
• Janus and PI3-kinases mediate glucocorticoid resistance in activated chronic leukemia cells. (Q36118340) (← links)
• Toll-like receptor agonists in the treatment of chronic lymphocytic leukemia (Q36635059) (← links)
• Toll-like receptors: key activators of leucocytes and regulator of haematopoiesis. (Q36952605) (← links)
• Obstacles to effective Toll-like receptor agonist therapy for hematologic malignancies (Q37051022) (← links)
• Toll-like receptors, transduction-effector pathways, and disease diversity: evidence of an immunobiological paradigm explaining all human illness? (Q37198685) (← links)
• Toll-like receptors: lessons to learn from normal and malignant human B cells (Q37203723) (← links)
• High-content screening identifies kinase inhibitors that overcome venetoclax resistance in activated CLL cells (Q37209768) (← links)
• Toll-like receptors and their role in carcinogenesis and anti-tumor treatment. (Q37354939) (← links)
• The role of toll-like receptors in chronic B-cell malignancies (Q37578343) (← links)
• Low Density Lipoproteins Amplify Cytokine-signaling in Chronic Lymphocytic Leukemia Cells (Q37584298) (← links)
• The Expression of Toll-Like Receptors in Patients with B-Cell Chronic Lymphocytic Leukemia. (Q37677971) (← links)
• Toll-like Receptors in Chronic Lymphocytic Leukemia (Q38042942) (← links)
• Stereotyped B-cell receptors in chronic lymphocytic leukemia (Q38176427) (← links)
• Toll-like receptors and B cells: functions and mechanisms (Q38213432) (← links)
• Toll-like receptors in the pathogenesis of human B cell malignancies (Q38238963) (← links)
• Modes of action of TLR7 agonists in cancer therapy (Q38271879) (← links)
• New drug discovery approaches targeting recurrent mutations in chronic lymphocytic leukemia (Q38646974) (← links)
• Regulatory B lymphocyte functions should be considered in chronic lymphocytic leukemia (Q38911219) (← links)
• Toll-like receptors targeting technology for the treatment of lymphoma (Q38948266) (← links)
• Lymphoblastoid cell line with B1 cell characteristics established from a chronic lymphocytic leukemia clone by in vitro EBV infection (Q39327432) (← links)
• Toll-like receptor 4 and 9 expression in B-chronic lymphocytic leukemia: relationship with infections, autoimmunity and disease progression (Q42243487) (← links)
• Local administration of a novel Toll-like receptor 7 agonist in combination with doxorubicin induces durable tumouricidal effects in a murine model of T cell lymphoma. (Q42247829) (← links)
• Prolonging microtubule dysruption enhances the immunogenicity of chronic lymphocytic leukaemia cells (Q43279666) (← links)
• Synergy of purine-scaffold TLR7 agonist with doxorubicin on systemic inhibition of lymphoma in mouse model (Q47135118) (← links)
• Maltose-binding protein isolated from Escherichia coli induces Toll-like receptor 2-mediated viability in U937 cells. (Q54356716) (← links)
• Active Toll-like receptor-7 triggering of chronic lymphocytic leukemia B-cells by imiquimod. (Q54631083) (← links)
• Harnessing cancer immunotherapy during the unexploited immediate perioperative period (Q89748459) (← links)
• Clinico-Biological Implications of Modified Levels of Cytokines in Chronic Lymphocytic Leukemia: A Possible Therapeutic Role (Q89896570) (← links)
• Agonist and antagonist ligands of toll-like receptors 7 and 8: Ingenious tools for therapeutic purposes (Q90594140) (← links)